EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14

Byung-Hak Song, Sang-Im Yun, Joseph L Goldhardt, Jiyoun Kim, Young-Min Lee iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1012844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Byung-Hak Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University, Logan, Utah, United States …. Hauptthemen laut MEDLINE: Encephalitis Virus, Japanese, Japanese Encephalitis Vaccines, Encephalitis, Japanese, Virulence Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Utah Science Technology and Research Initiative, Utah Agricultural Experiment Station, Utah Science Technology and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Japanese encephalitis virus (JEV), a neuroinvasive and neurovirulent orthoflavivirus, can be prevented in humans with the SA 14 -14-2 vaccine, a live-attenuated version derived from the wild-type SA 14 strain. To determine the viral factors responsible for the differences in pathogenicity between SA 14 and SA 14 -14-2, we initially established a reverse genetics system that includes a pair of full-length infectious cDNAs for both strains. Using this cDNA pair, we then systematically exchanged genomic regions between SA 14 and SA 14 -14-2 to generate 20 chimeric viruses and evaluated their replication capability in cell culture and their pathogenic potential in mice. Our findings revealed the following: ( i ) The single envelope (E) protein of SA 14 -14-2, which contains nine mutations (eight in the ectodomain and one in the stem region), is both necessary and sufficient to render SA 14 non-neuroinvasive and non-neurovirulent. ( ii ) Conversely, the E protein of SA 14 alone is necessary for SA 14 -14-2 to become highly neurovirulent, but it is not sufficient to make it highly neuroinvasive. ( iii ) The limited neuroinvasiveness of an SA 14 -14-2 derivative that contains the E gene of SA 14 significantly increases (approaching that of the wild-type strain) when two viral nonstructural proteins are replaced by their counterparts from SA 14 : ( a ) NS1/1’, which has four mutations on the external surface of the core β-ladder domain; and ( b ) NS2A, which has two mutations in the N-terminal region, including two non-transmembrane α-helices. In line with their roles in viral pathogenicity, the E, NS1/1’, and NS2A genes all contribute to the enhanced spread of the virus in cell culture. Collectively, our data reveal for the first time that the E protein of JEV has a dual function: It is the master regulator of viral neurovirulence and also the primary initiator of viral neuroinvasion. After the initial E-mediated neuroinvasion, the NS1/1’ and NS2A proteins act as secondary promoters, further amplifying viral neuroinvasiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis Virus, JapaneseJapanese Encephalitis VaccinesEncephalitis, JapaneseVirulence FactorsAnimalsVaccines, AttenuatedMiceVirulenceHumansViral Envelope ProteinsVirus ReplicationFemale

Substanzen

Japanese Encephalitis VaccinesVaccines, AttenuatedVirulence FactorsViral Envelope Proteins

Autor:innen und Institutionen

  • Department of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University, Logan, Utah, United States of America.

ORCID-Profile: Young-Min Lee

Förderung

  • Utah Science Technology and Research Initiative
  • Utah Agricultural Experiment Station
  • Utah Science Technology and Research

Zitieren

APA

Song, B. H., Yun, S. I., Goldhardt, J. L., Kim, J., & Lee, Y. M. (2025). Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012844

Vancouver

Song BH, Yun SI, Goldhardt JL, Kim J, Lee YM. Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1012844

BibTeX
@article{Song2025,
  author = {Song, Byung-Hak and Yun, Sang-Im and Goldhardt, Joseph L and Kim, Jiyoun and Lee, Young-Min},
  title = {Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1012844}
}
Kostenlos starten →